Answers are grounded in this paper and cite their sources.
Tumor angiogenesis is sustained not only by endothelial activation but also by adaptive reprogramming of the perivascular niche. Tetraspanin Kai1 (CD82) functions as a pericyte-intrinsic suppressor of angiogenic activation, yet the mechanisms underlying its loss within angiogenic tumor microenvironments remain poorly understood. Here, we demonstrate that PDGF-BB and basic fibroblast growth factor (bFGF), but not VEGF-A, reduce Kai1 expression in murine pericyte-like model. Mechanistically, PDGFR/FGFR signaling is associated with a dual-layer regulatory program: (1) Src-sensitive increases in DNMT1 and DNMT3A are associated with increased Kai1 promoter methylation and reduced transcription; and (2) PKC-sensitive, Flotillin-1-associated trafficking contributes to Kai1 internalization and lysosomal degradation. Functionally, DNMT inhibition or lysosomal blockade restored Kai1 levels and attenuated growth factor-induced sprout outgrowth in 3D spheroids. In vivo, combined DNMT and lysosomal inhibition reduced tumor growth in WT mice, whereas a comparable reduction was not observed in Kai1 KO mice. Collectively, our findings identify a growth factor–programmed “off-switch” that disables a pericyte-intrinsic anti-angiogenic brake. These findings nominate pericyte Kai1 regulation as a potential mechanism for future investigation in VEGF-independent vascular remodeling.
No takes yet. Share an insight, caveat, or question.
Chae et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: